|
|
Volumn 9, Issue 6, 2000, Pages 1397-1406
|
|
Evaluation of memantine for neuroprotection in dementia
|
|
Author keywords
Alzheimer's disease; Dementia; Excitotoxicity; Glutamate; HIV 1 dementia; Huntington's disease; Ion channels; Memantine; Neurodegenerative disorders; Neuroprotection; NMDA receptor blockers; Pick's disease; Vascular dementia
|
|
Indexed keywords
BARBITURIC ACID DERIVATIVE;
CHOLINESTERASE INHIBITOR;
DIZOCILPINE;
MEMANTINE;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;
NEUROLEPTIC AGENT;
AGED;
ALZHEIMER DISEASE;
AMNESIA;
AMYOTROPHIC LATERAL SCLEROSIS;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ATAXIA;
CHRONIC PAIN;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEMENTIA;
DOUBLE BLIND PROCEDURE;
DRUG APPROVAL;
DRUG DEPENDENCE;
DRUG EFFICACY;
DRUG MARKETING;
DRUG SAFETY;
EPILEPSY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
MULTIINFARCT DEMENTIA;
NAUSEA;
NEUROPROTECTION;
NEUROTOXICITY;
NONHUMAN;
PARKINSON DISEASE;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
RAT;
REVIEW;
SIDE EFFECT;
STROKE;
VERTIGO;
|
|
EID: 0034036257
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.9.6.1397 Document Type: Review |
|
Times cited : (110)
|
|
References (35)
|
